Imbruvica 140 mg capsules are used for cancer treatment. They act by means of providing very specific, targeted therapy. These inhibit the mechanism of Bruton’s tyrosine kinase (BTK).
BTK is a very important signaling molecule that belongs to the B-cell receptor signaling complex. BTK has a vital role to play in the survival of cancerous, malignant B cells.
Imbruvica Ibrutinib 140 mg Capsules help to block the signals which stimulate the growth and rapid division of the malignant B.
Imbruvica Ibrutinib 140 mg capsules are used to treat some types of non-Hodgkin lymphoma like the mantle cell lymphoma (MCL),chronic lymphocytic leukemia (CLL) and Waldenstrom’s macroglobulinemia.
It is also put to use in treating patients with or without 17p deletion in small lymphocytic lymphoma (SLL). However, it’s efficiency in these cases is questionable.
This is not a full list of all side effects that may occur with Imbruvica Ibrutinib 140 mg Capsules.Please seek medical advice from your doctor about side effects that become worrisome.
- Loose motions
- Nausea and vomiting
- Pallor of skin
- Patient tends to bleed and bruise easily
- Chills and fever with flu like symptoms
- Muscle and bone aches
- Pain in chest
- Feeling of dizziness
- Irregular heartbeat and palpitation
- Difficulty in breathing
- Mouth and skin sores
- Swollen gums
- You must always inform your doctor of pharmacist about your past and present drug allergies or other allergies before taking this medication.Drug allergies to both active ingredients and inactive agents are common.